CTA Expression/Methylation and Response to Pembrolizumab of NSCLC Patients
Clinical trial NCT03571360 · UNKNOWN
Trial details
- NCT number
- NCT03571360
- Sponsor
- Medical University of Vienna
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2021-01-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.